Financial-statement observations. The income period begins at commencement of operations; it is not a full quarter. Later NAV disclosures are shown separately.
NAV per share
45.93USD per share · At 30 June 2026
Common net assets
4,592.534836USD million · At 30 June 2026
Investment income
19.505866USD million · 29 April–30 June 2026 · commencement-to-date
Net investment income
2.048289USD million · 29 April–30 June 2026 · commencement-to-date
Definitions, sources and limitations
NAV per share Reported. Reported fund financial statements. NAV per share is rounded as disclosed. Source disclosure
Common net assets Reported. Reported fund financial statements. NAV per share is rounded as disclosed. Source disclosure
Investment income Reported. Reported fund financial statements. NAV per share is rounded as disclosed. Source disclosure
Net investment income Reported. Reported fund financial statements. NAV per share is rounded as disclosed. Source disclosure
Figures use the same dataset as the interactive history, displayed in the stated units with up to six decimal places. Reporting periods are not editorial review dates. Missing values are not zero. Date definitions · Published corrections
Own this fund’s residual investments.
PSUS common shareholders own the assets remaining after liabilities and preferred claims. The manager selects investments and charges fees; it does not guarantee their result. PSUS uses direct shares and derivatives, with its own portfolio and start date.
Each ticker is a different ownership claim. PS earns management income; PSH and PSUS hold separate investment portfolios. Shared management creates overlapping exposures, not identical shareholder results.
The US fund shareholder’s flywheel
1 · Establish investable capital
Capital raised must be assessed after launch costs, not just the headline offering amount.
Reported evidence: US$50 IPO price became US$48.79 commencement NAV per common share after the disclosed costs.
2 · Put capital to work
Underlying businesses and selected exposures drive investment gains and income.
Reported evidence: At 30 June: US$2.469bn direct common stocks and US$1.590bn equity-forward inception notional; notional is not an asset value.
3 · Retain the result after costs
Income and capital gains or losses both matter. Management and fund expenses reduce what remains.
Reported evidence: Investment income US$19.506m less expenses US$17.458m = US$2.048m net investment income, yet reported NAV total return was −8.15% from IPO price.
4 · Follow the common shareholder outcome
Retained capital participates in later results; market pricing creates another layer for the listed shareholder.
Reported evidence: At 30 June reported NAV was US$45.93 and price US$37.38; market total return from IPO price was −25.24%.
A reinforcing cycle requires worthwhile investment outcomes retained after costs. Raising more capital alone does not create NAV per existing share. These first operating-period observations show losses and launch effects, not proof that a positive cycle has been established.
Common NAVUS$4.593bn30 Jun 2026Why track this?
What it measures
US$4.768684bn assets − US$126.149m liabilities − US$50m preferred claim = US$4.592535bn common net assets.
Why it matters
Shows the residual assets belonging to common shareholders.
What it can affect next
Investment changes and obligations alter what each common share represents.
What could mislead you
Total assets and manager AUM are different claims. Dividing by 100m common shares gives an unrounded NAV of US$45.9253.
Primary disclosure ↗NAV / common shareUS$45.9330 Jun 2026 · reported roundedWhy track this?
What it measures
Fund net assets allocated across 100m common shares. IPO price was US$50; commencement NAV was US$48.79 after costs.
Why it matters
Separates the assets received at launch from the price subscribers paid.
What it can affect next
Launch costs reduce initial invested capital before later performance.
What could mislead you
Opening and ending reported NAVs are rounded. IPO costs are already reflected; do not deduct them again.
Primary disclosure ↗Shareholder price and discountUS$37.38 · 18.62% discount30 Jun 2026 · reportedWhy track this?
What it measures
Market price compared with same-date common NAV.
Why it matters
The market can price a closed-ended fund below its recorded assets.
What it can affect next
Discount widening can deepen a shareholder loss relative to the portfolio result.
What could mislead you
Published rounded quotes reproduce the reported 18.62%. Using exact common net assets divided by shares gives 18.61%; the rounding bases are kept explicit. Discount is not a stock recommendation.
Primary disclosure ↗NAV / market total return−8.15% / −25.24%29 Apr–30 Jun 2026 · reportedWhy track this?
What it measures
Both returns use the US$50 IPO price as their initial basis.
Why it matters
Shows how fund assets and traded shares delivered different outcomes.
What it can affect next
Market-price changes add a separate layer to the portfolio outcome.
What could mislead you
These are short inception-period returns, not annualised returns or a full-quarter comparison. Do not splice in PSH history.
Primary disclosure ↗Management / total expensesUS$16.536m / US$17.458m29 Apr–30 Jun 2026Why track this?
What it measures
Management fees plus professional, trustee and other expenses. The contractual management rate is 2% of common NAV annually; no performance fee.
Why it matters
Measures the cost borne by this fund’s common owners.
What it can affect next
Costs reduce capital left invested and compound over time.
What could mislead you
The report’s 2.12% expense ratio is annualised. The dollar expenses cover only the short reported operating period.
Primary disclosure ↗Preferred capital and derivativesUS$50m preferred30 Jun 2026Why track this?
What it measures
Preferred shares had a 7.5% cumulative coupon. Equity forwards had US$1.590bn inception-price notional and US$122.684m unrealised depreciation.
Why it matters
Common owners carry claims and exposures beyond direct stock holdings.
What it can affect next
Preferred distributions and derivative financing or collateral needs can consume resources after market losses.
What could mislead you
Forward notional is exposure, not a balance-sheet asset to add to NAV. Treasury collateral of US$502.105m was pledged.
PSUS began operations on 29 April 2026. There are no five completed years of PSUS results.
Observation
US$ / common share
Basis
IPO price
50.00
Price paid in the offering
Commencement NAV
48.79
After launch costs and pre-operation expenses
30 June NAV
45.93
Reported, rounded
30 June market price
37.38
Same-date traded price
IPO price
US$50.00
Opening NAV
US$48.79
June NAV
US$45.93
June price
US$37.38
These bars compare distinct measures and dates; they are not a continuous NAV performance series. The report calculates the −8.15% NAV return and −25.24% market return from the IPO price, not from the commencement NAV. No annual return is inferred.
Cash income is only one component
29 April–30 June · US$m
Amount
Dividend and interest income
19.506
Management fees
16.536
Total expenses
17.458
Net investment income
2.048
Positive net investment income can coexist with a net loss because capital values and derivatives also change. The fund’s first report includes a US$50m preferred claim ahead of common holders.
Direct common-stock values from PSUS’s investment schedule. These are not PSH allocations or manager-wide 13F weights. Direct-share percentages below use US$4.592535bn common NAV; they omit additional equity-forward exposures.
Direct stock
US$m
Calculated % of common NAV
Amazon
378.937
8.25%
Visa
257.085
5.60%
Mastercard
254.232
5.54%
S&P Global
235.448
5.13%
Uber
226.661
4.94%
Netflix
225.367
4.91%
Meta
210.975
4.59%
Brookfield Corporation
207.417
4.52%
Microsoft
204.824
4.46%
Restaurant Brands
134.869
2.94%
Fannie Mae
79.833
1.74%
Freddie Mac
53.705
1.17%
Why a large Treasury balance is not the whole exposure picture
Investment / exposure
US$m
Meaning
Direct common stocks
2,469.353
Recorded security values
Money market funds
1,698.009
Treasury-oriented short-term investments
Treasury bill
598.801
Includes US$502.105m pledged as derivative collateral
Equity-forward inception notional
1,589.528
Exposure reference amount, not an additional asset
Equity-forward unrealised depreciation
122.684
Liability already included in common NAV
Forwards referenced Meta, Restaurant Brands, Brookfield Corporation, Microsoft and Uber. Their financing and settlement terms affect cash needs. Do not add notional to recorded assets or interpret all short-term investments as uncommitted cash.
Common stocks US$2,469.353m + money markets US$1,698.009m + Treasury bill US$598.801m = US$4,766.163m securities. Other assets and liabilities, then preferred capital, reconcile to common NAV. Securities alone can exceed common NAV because there are claims and derivative liabilities.
PSUS invests its own portfolio under the shared manager’s approach.
Investment gains and income change its net assets after its expenses and senior claims.
Retained capital participates in subsequent investment results; issuance, distributions and repurchases change the per-share position.
Common-shareholder total return combines market-price changes and distributions; its own discount or premium can change independently of PSH’s.
The shareholder test: examine PSUS’s own net result per common share. Similar management does not make its portfolio, cash balance, leverage, entry dates, fee burden or traded discount identical to PSH. Additional assets can benefit the manager without necessarily improving existing PSUS shareholders’ NAV per share.
NAV total return and NAV per common share
What it measures
NAV is assets less liabilities and senior claims, divided by the relevant common shares. NAV total return includes distributions on the stated reinvestment basis.
Why it matters
Tests the portfolio outcome after fund-level expenses rather than the size of the fund.
What it can affect next
Retained investment gains can support a larger invested capital base; losses reduce it.
What could mislead you
NAV per share alone omits distributions. Do not add portfolio-company earnings to their securities’ values again.
Shareholder total return and discount / premium
What it measures
Total return follows the traded share price and distributions. Discount = 1 − market price / same-date NAV per share, in the same currency.
Why it matters
Separates the fund’s investment result from what a listed shareholder experienced.
What it can affect next
A widening discount can offset NAV gains; narrowing can amplify market-price gains. Neither is guaranteed.
What could mislead you
Discount narrowing is not an operating flywheel or proof of investment merit. PSH and PSUS have separate market prices and NAVs.
Actual expenses and fee drag
What it measures
Management fees, applicable performance fees, operating expenses and financing costs borne by the fund.
Why it matters
Identifies how much of the gross investment result is retained by shareholders.
What it can affect next
Recurring expenses reduce capital left invested; performance-fee offsets can reduce the relevant expense when applicable.
What could mislead you
Published fee rates are not total expense ratios. Net NAV returns already include applicable costs; do not subtract them twice.
Debt, preferred claims, cash and liquidity
What it measures
Borrowing and any preferred capital sit ahead of common shares; usable liquidity must cover obligations.
Why it matters
Shows how much exposure and financing risk each common share carries.
What it can affect next
Losses reduce common equity while senior claims remain; margin, refinancing or payout needs can constrain portfolio decisions.
What could mislead you
Use the instrument’s own disclosed capital structure. Do not copy PSH debt or leverage ratios into PSUS, or treat restricted cash as freely available.
Portfolio concentration and underlying business cash generation
What it measures
Position weights describe exposure; company earnings, cash flow and balance sheets help explain that exposure.
Why it matters
Connects movements in NAV to the economics of the businesses held.
What it can affect next
Weakness across related holdings can affect several positions at once; common management does not create independent diversification.
What could mislead you
PSH, PSUS and manager-wide 13F disclosures have different perimeters and dates. Do not assign 13F weights to either fund’s NAV.
Share issuance, repurchases and distributions
What it measures
Changes in the common share count and cash transferred into or out of the fund.
Why it matters
Tests whether capital allocation changes NAV and exposure for each remaining share.
What it can affect next
Repurchases below NAV can increase NAV per remaining share before costs, while reducing fund cash. Issuance has its own per-share economics.
What could mislead you
A larger fund is not automatically better for existing owners. Distributions transfer assets out; they do not create an extra layer of return.
PSUS began trading in April 2026. It does not have PSH’s standalone multi-year record; do not splice PSH’s earlier returns into a PSUS history. The combined IPO included PS shares for eligible original participants. Buying PSUS later does not automatically convey a separate allocation of PS shares.
How the fees connect · benefits and trade-offs between shareholders
Contractual manager fees · not total expense ratios
Arrangement
PSH
PSUS
Annual management rate
1.5% of fee-paying NAV before accrued performance fees
2% of NAV
Performance fee
16% of qualifying NAV appreciation above a high-water mark, subject to reductions
No performance fee
Fee offset: PSH’s contractual performance-fee reduction includes 20% of qualifying PSUS management fees. It reduces PSH’s applicable performance-fee burden, rather than being a cash dividend from PSUS to PSH. Unused offsets carry forward under the agreement; they do not guarantee an immediate cash benefit.
Second-order effect: more PSUS fee-paying capital can generate more management revenue for PS, while increasing the offset against PSH performance fees. Assess the net effect after offsets, costs and compensation. Growing PSUS assets is not itself an investment gain for PSUS common shareholders.
Repurchase trade-off: a PSH repurchase below NAV can raise NAV per remaining PSH share before costs, yet reduces fund assets and can reduce the manager’s fee base. What helps one instrument’s per-share arithmetic need not enlarge the other’s revenue.
First operating period: 29 April–30 June 2026. Balance sheet and investment schedule: 30 June 2026. Source printed pp.16–22, management agreement and preferred-share notes.
Investment and people
Weak investment results, key-person dependence and governance choices can affect several Pershing vehicles at once.
Costs and capital claims
Compensation, fees, tax, financing and dilution determine the result per common share. Use this instrument’s own accounting perimeter.
Market pricing
Market multiples or fund discounts can change independently of operating progress. Historical operating relationships do not promise shareholder returns.
Reported values and calculated arithmetic are labelled. Interpretation explains possible relationships; missing histories are not filled with another instrument’s results. Rounding can affect sums and ratios.
About this information centre
Historical data and business explanations only. No forecasts, price targets or stock recommendations.
This site explains company operations, fund structures, financial statements and key metrics. Coverage reflects subjects being studied, not a ranked shortlist or an endorsement. It provides no buy, hold or sell recommendations, personal investment advice, or invitation to invest in a fund.
Reported observations, calculated measures, management commentary and editorial interpretation are distinguished by their labels and sources. Dates, currencies, accounting definitions and disclosure gaps matter. Figures are dated snapshots and may change; past performance does not establish future results.
Historical NAV growth, financial results and dated ratios describe past observations. This site does not forecast results or recommend stocks. Research notes are written by the user and do not generate investment assessments.
Company coverage and reported portfolio holdings do not constitute a model portfolio. A description of a company’s purchases, sales or share repurchases records its activity; it is not an instruction to readers. This educational scope does not constitute FCA approval or a legal compliance certification.